Regulatory changes impacting SPACs or healthcare investments could limit acquisition opportunities.
Market saturation in the SPAC space may lead to increased competition for high-quality targets.
Emergence of new SPACs targeting the same healthcare sectors could dilute potential acquisition targets.
Traditional private equity firms may outbid SPACs for attractive healthcare assets.
Low liquidity due to a lack of operational revenue, which could hinder the ability to pursue acquisitions.
Potential for significant write-downs if acquired companies underperform post-merger.
StructuralCompetitiveBalance Sheet